Eye Care Professionals

02/03/2026

Adjunctive Crosslinking and/or Steroids May Not Improve Bacterial Keratitis Outcomes

Adding corticosteroids to traditional antibiotic therapy, with or without the addition of corneal crosslinking, does not appear to positively impact bacterial keratitis treatment outcomes.

02/02/2026

AOA on Capitol Hill 2025: Live News Updates https://www.aoa.org//news/advocacy/federal-advocacy/aoa-on-capitol-hill-2025-live-news

02/01/2026

AOA teams up with K**e Hernández to champion eye health https://www.aoa.org//news/inside-optometry/aoa-news/aoa-teams-up-with-kike-hernandez-to-champion-eye-health

01/31/2026

mRNA vaccine shows promise for treating age-related macular degeneration https://medicalxpress.com/news/2025-09-mrna-vaccine-age-macular-degeneration.html

An mRNA vaccine developed by researchers from Japan suppressed abnormal blood vessel growth or neovascularization in the retina of mouse models. Neovascularization is a condition that is caused by age-related macular degeneration (AMD), a leading cause of vision loss for elderly people. The vaccine....

01/30/2026

Week in Review: Retinal OCT Imaging to Detect Atherosclerosis, Patient Income and Glaucoma Care, RPE Replacement Therapy for AMD Vision Loss

Arterial disease could be detected in asymptomatic people via microvascular OCT angiography, patients in lower-income brackets may be less likely to receive timely glaucoma care, and retinal pigment e

01/29/2026

Polyunsaturated fatty acid therapy reverses age-related vision decline in mice https://medicalxpress.com/news/2025-09-polyunsaturated-fatty-acid-therapy-reverses.html

Changes in vision are often a common sign of aging. But what if we could reverse age-related visual decline? In a new study, UC Irvine researchers explore a possible therapy for addressing "aging" in the eye and for preventing diseases such as age-related macular degeneration (AMD).

01/28/2026

Similar Postsurgical Outcomes Are Seen With External and Endoscopic Dacryocystorhinostomy

A retrospective cohort study reviewed data from the TriNetX electronic health record registry to evaluate 20-year annual surgical volume trends in the use of external vs endoscopic dacryocystorhinosto

01/27/2026

Weekly Journal Update — September 24, 2025

Safety of teprotumumab vs glucocorticoids, home-based nAMD monitoring, phenotypic variability of Best vitelliform macular dystrophy, EDOF monofocal IOLs, blood-based biomarkers for 2 infectious orbita

01/26/2026

‘Living an episode of Black Mirror:’ AI deepfakes target optometrist https://www.aoa.org//news/clinical-eye-care/public-health/living-an-episode-of-black-mirror-ai-deepfakes-target-optometrist

01/25/2026

Adult stem cells show therapeutic promise in treating vision loss from macular degeneration https://medicalxpress.com/news/2025-09-adult-stem-cells-therapeutic-vision.html

In the United States, age-related macular degeneration is a leading cause of irreversible vision loss in people who are 60 and older.

01/24/2026

Giant Cell Arteritis Risk May Be Elevated in Patients With Herpes Zoster Ophthalmicus

Patients with herpes zoster ophthalmicus (HZO) could be up to 3 times more likely to develop giant cell arteritis than patients without HZO, according to a retrospective cohort study.

01/23/2026

Experimental eyedrop formula delivers protective compounds for serious vision problems https://medicalxpress.com/news/2025-09-experimental-eyedrop-formula-compounds-vision.html

A new eyedrop has shown early success in delivering protective compounds to where they're needed most in the eye, raising hopes for less invasive treatment of serious vision conditions.